• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Jun,YANG Guang,SHEN Mengxin,LIU Yuanyuan,YANG Zhanqiu.Antiviral activity of Xiaoer Baotaikang Granules against respiratory viruses in vitro[J].Journal Of Pharmaceutical Research,2022,41(8):491-495,544[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2561times   Download 2036次 QR Code for this article
Scan with your phone!
小儿宝泰康颗粒对呼吸道病毒感染的抗病毒作用研究
刘军1,杨光2,沈梦欣2,刘媛媛1,杨占秋1
Font:Larger+|Default|Smaller-
(1.武汉大学基础医学院医学病毒学研究所,湖北 武汉 430071;2.湖北省妇幼保健院检验科,湖北 武汉 430070)
摘要:
目的 观察小儿宝泰康颗粒对呼吸道合胞病毒和腺病毒感染细胞的抑制作用,以便为呼吸道病毒感染的治疗提供新的药物。方法 通过细胞培养技术观察不同浓度的小儿宝泰康颗粒对HEp-2细胞的细胞毒作用,采用MTT法并结合CPE法检测病毒感染细胞存活率和病毒抑制率,以利巴韦林作为阳性药物对照,评价该药物对呼吸道合胞病毒和腺病毒感染细胞的抗病毒活性。结果 小儿宝泰康颗粒对HEp-2细胞的半数细胞毒性浓度(TC50)为4.4 mg·mL-1,对呼吸道合胞病毒的半数有效浓度(EC50)为2.03 mg·mL-1,而腺病毒的EC50为0.65 mg·mL-1,抗病毒指数分别为2.17和6.75。在对两种病毒的直接灭活作用中,EC50分别为4.13和8.99 mg·mL-1。阳性对照药物病毒唑在128 g·mL-1时,对呼吸道合胞病毒和腺病毒的抑制率分别为92.7%和80.16%。结论 小儿宝泰康颗粒是一种对呼吸道合胞病毒和腺病毒感染有抗病毒作用的药物,有临床应用前景和进一步研究的价值。
关键词:  小儿宝泰康颗粒  呼吸道合胞病毒  腺病毒  抗病毒作用  细胞实验
DOI:10.13506/j.cnki.jpr.2022.08.001
基金项目:国家自然科学基金(No.30873104)
Publication Date:August 25, 2022
Antiviral activity of Xiaoer Baotaikang Granules against respiratory viruses in vitro
LIU Jun1,YANG Guang2,SHEN Mengxin2,LIU Yuanyuan1,YANG Zhanqiu1
(1.Institute of Medical Virology, School of Basic Medicine, Wuhan University, Wuhan 430071,China;2.Maternal and Child Health Hospital of Hubei province, Wuhan 430070,China)
Abstract:
Objective To investigate the antiviral activity of Xiaoer Baotaikang Granules on respiratory syncytial virus(RSV) and adenovirus(AdV) in vitro.Methods The cell viabilities of the Xiaoer Baotaikang Granules were determined by MTT assay on HEp-2 cells. Cytopathic effect (CPE) observation and MTT assay were applied to evaluate the antiviral activity of Xiaoer Baotaikang Granules and ribavirin was used as positive control drug. Results The TC50 value of Xiaoer Baotaikang Granules on HEp-2 cells was 4.4 mg·mL-1. Furthermore,Xiaoer Baotaikang Granules had inhibitory activity on viral replication in vitro with EC50 of 2.03 mg·mL-1 and 0.65 mg·mL-1 on RSV and AdV, resulting in TI of 2.17 and 6.75 respectively. In the virucidal activity, the ED50 of Xiaoer Baotaikang Granules against RSV and AdV was 4.13 and 8.99 mg·mL-1,respectively. Comparatively, inhibition rate was 92.7% and 80.16% against RSV and AdV in ribavirin control group. Conclusion Xiaoer Baotaikang Granules has antiviral activity against RSV and AdV on HEp-2 cells.
Key words:  Xiaoer Baotaikang Granules  Respiratory syncytial virus  Adenovirus  Antiviral activity  In vitro
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.